A Randomized Phase II Trial of Two Dose Schedules of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer.
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Carboplatin (Primary) ; Cetuximab (Primary) ; Paclitaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors ImClone Systems
- 13 Oct 2009 Actual initiation date changed from Dec 2004 to Nov 2004 as reported by ClinicalTrials.gov.
- 01 Oct 2008 Actual number of patients enrolled was 160 according to Clinicaltrials.gov record.
- 16 Aug 2005 New trial record.